XML 172 R50.htm IDEA: XBRL DOCUMENT v3.25.2
SEGMENT REPORTING (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2025
Dec. 31, 2024
Segment Reporting [Abstract]    
SCHEDULE OF INFORMATION RELATED TO OPERATIONS OF REPORTABLE OPERATING SEGMENTS

The following table presents information about the Company’s reportable segments for the six and three months ended June 30, 2025 and 2024:

 

   2025   2024   2025   2024 
   Six months ended   Three months ended 
   June 30   June 30 
   2025   2024   2025   2024 
                 
Revenue from pathogen prevention and prolong shelf life   66    61    -    17 
Cost related to pathogen prevention and prolong shelf life   (582)   (528)   (314)   (221)
Operating loss from Pathogen prevention and prolong shelf life   (516)   (467)   (314)   (204)
                     
Revenue from renewable energy projects   -    -    -    - 
Cost related to renewable energy projects   (130)   -    (59)   - 
Operating loss from Renewable energy projects   (130)   -    (59)   - 
                     
Professional services   (557)   (631)   (356)   (400)
Share base compensation   (2,029)   (260)   (1,988)   (121)
Depreciation   (3)   (7)   (1)   (3)
Other general and administrative expenses   (217)   (263)   (114)   (119)
Total Operating loss   (3,452)   (1,628)   (2,832)   (847)
                     
Interest of loans   

(77

)   -    

-

    

-

 
Financing expenses, net   (1,934)   (74)   (1,203)   (79)
Other gain   3    105    3    117 
Changes in fair value of investments measured under the fair value option   (349)   114    (520)   30 
Net loss   (5,809)   (1,483)   (4,552)   (779)

Operating loss related to the Company’s reportable segments and the reconciliation of the total net loss attributable to common stockholders is as follows:

 

 

   2024   2023 
   Year ended December 31 
   2024   2023 
         
Revenue from Pathogen prevention and prolong shelf life   210    263 
Cost related to Pathogen prevention and prolong shelf life   (896)   (1,361)
Operating loss from Pathogen prevention and prolong shelf life   (686)   (1,098)
           
Revenue from N2O emissions Global warming solutions   -    - 
Cost related to N2O emissions Global warming solutions   (350)   (1,788)
Operating loss from N2O emissions Global warming solutions   (350)   (1,788)
           
Professional services   (2,009)   (1,831)
Share base compensation   (1,055)   (2,444)
Depreciation   

(18

)   

(21

)
Other general and administrative expenses   (202)   (396)
Total Operating loss   (3,284)   (4,692)
           
Financing (expenses) income, net   (155)   47 
Other income   428    985 
Changes in fair value of investments measured under the fair value option   (1,300)   (714)
Net loss   (5,347)   (7,260)
SCHEDULE OF INFORMATION ON SALES BY GEOGRAPHIC DISTRIBUTION  

Sales are attributed to geographic distribution based on the location of the customer.

 

   2024   2023 
   Year ended December 31 
   2024   2023 
         
United States   171    142 
Mexico   -    110 
Israel   31    10 
Peru   8    - 
Turkey   -    1 
Revenues from sales   210    263 
SCHEDULE OF SALES TO CUSTOMERS  

 

   2024   2023 
   Year ended December 31 
   2024   2023 
         
Customer A   171    143 
Customer B   -    110 
Customer C   31    - 
Revenues from sales   202    253 
SCHEDULE OF INFORMATION ON LONG LIVED ASSETS  

The following table presents the locations of the Company’s long-lived assets as of December 31, 2024 and 2023:

 

   2024   2023 
   Year ended December 31 
   2024   2023 
         
Israel   43    102 
United States   13    21 
Property, plant and equipment and ROU assets   56    123